Sinil Pharmaceutical Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Mi-Keun Jung
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.9% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?
Mar 11
Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?
Feb 13
Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?
Jan 17Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?
Dec 22Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Nov 26CEO
Mi-Keun Jung (69 yo)
no data
Tenure
Mr. Mi-Geun Jung serves as the Chief Executive Officer and President at Shinil Pharmaceutical Co., Ltd. Mr. Jung served as a Vice President and Factory Manager of Shinil Pharmaceutical Co., Ltd. He served...